Healthcare Sector

Over the course of two sessions, the stock has gained approximately 12%, with a significant 7% increase observed on June 20 after a large deal.

The objective of this partnership is to tackle the increasing occurrence of Cardiovascular Diseases (CVD) and Chronic Obstructive Pulmonary Disease (COPD) in the Palghar district of Maharashtra.

Taiho Oncology Inc. sells Lonsurf in the United States.

The study will continue for approximately 56 weeks.

The company will manufacture the product at the group’s formulation facility located in Moraiya, Ahmedabad (India).

This is the 27th international GMP approval for Venus Remedies.

FPP Holding serves as the parent company for Florida Pharmaceutical Products, LLC (FPP).

In terms of pharmacodynamic parameters, the clinical trial confirmed DRL_TC's similarity to the EU and US reference products.

Earlier in November 2021, Laurus acquired a 26.62% stake in ImmunoACT.

According to the study, docetaxel-based treatment has improved survival rates in men with castration-sensitive prostate cancer.